Irina Kessel

This inventor holds 4 USPTO granted patents. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2009-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irina Kessel. Retrieved from https://idiyas.com/inventor/irina-kessel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 9(Granted Patents)

Location History:

Maoz-Zion, IL (2009)
Tzur-Hadassa, IL (2011)
Swansea, GB (2012)

Company Filing History:

4 out of 915

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

patents

Years Active: 2009-2012

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8193311 - CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases (2012-06-05),

2. 7901909 - CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases (2011-03-08),

3. 7883857 - CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases (2011-02-08),

4. 7534605 - CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases (2009-05-19),

Title: Irina Kessel: Innovator in Inflammatory Disease Research

Introduction

Irina Kessel is a prominent inventor based in Tzur-Hadassa, Israel. She has made significant contributions to the field of biomedical research, particularly in the area of inflammatory diseases. With a total of 4 patents to her name, Kessel's work has the potential to impact the diagnosis and treatment of various health conditions.

Latest Patents

Among her latest patents, Kessel has developed innovative solutions involving CD44 polypeptides and their applications. One of her notable patents describes an isolated polypeptide that includes an antigen recognition domain capable of specifically binding a CD44 polypeptide, as set forth in SEQ ID NO: 2. This polypeptide is designed to be incapable of binding to certain other CD44 polypeptides, specifically those identified as SEQ ID NO: 4 or 6. This advancement holds promise for diagnosing and treating inflammatory diseases.

Career Highlights

Irina Kessel is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her work at this esteemed institution has allowed her to explore groundbreaking research and contribute to the scientific community. Kessel's dedication to her field is evident in her innovative approaches to complex medical challenges.

Collaborations

Throughout her career, Kessel has collaborated with notable colleagues, including David Naor and Shlomo Nedvetzki. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic strategies.

Conclusion

Irina Kessel's contributions to the field of inflammatory disease research exemplify her commitment to innovation and scientific advancement. Her patents and collaborations reflect her significant role in the ongoing quest for effective medical solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]